Stratec (ETR:SBS) Reaches New 12-Month Low at $92.70

Stratec SE (ETR:SBSGet Rating) reached a new 52-week low during trading on Thursday . The company traded as low as €92.70 ($97.58) and last traded at €94.70 ($99.68), with a volume of 27313 shares. The stock had previously closed at €98.90 ($104.11).

A number of brokerages recently issued reports on SBS. Warburg Research set a €116.00 ($122.11) price objective on Stratec in a research note on Thursday, May 5th. Berenberg Bank set a €125.00 ($131.58) price objective on Stratec in a research report on Thursday, April 21st. Finally, Deutsche Bank Rese… set a €138.00 ($145.26) target price on Stratec in a report on Friday, May 6th.

The company has a debt-to-equity ratio of 41.45, a quick ratio of 2.13 and a current ratio of 4.12. The stock has a fifty day moving average of €110.71 and a 200-day moving average of €119.79. The company has a market cap of $1.15 billion and a PE ratio of 29.57.

Stratec Company Profile (ETR:SBS)

Stratec SE, together with its subsidiaries, designs and manufactures automation and instrumentation solutions in the fields of in-vitro diagnostics and life sciences in Germany, European Union, and internationally. It operates through three segments: Instrumentation, Diatron, and Smart Consumables. The Instrumentation segment designs and manufactures automated analyzer systems, including service parts and consumables for clinical diagnostics and biotechnology customers.

Further Reading

Receive News & Ratings for Stratec Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stratec and related companies with's FREE daily email newsletter.